Travere Therapeutics, Inc. Insider Transactions
Travere Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 48 @ $13.14 | $631 | 89,990 | 04/11/2025 | 04/14/2025 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 2,568 @ $23.53 | $60.43 K | 89,602 | 02/12/2025 | 02/12/2025 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 2,568 @ $23.53 | $60.43 K | 125,066 | 02/12/2025 | 02/12/2025 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 8,000 @ $23.53 | $188.24 K | 89,482 | 02/12/2025 | 02/12/2025 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 5,200 @ $23.53 | $122.36 K | 98,519 | 02/12/2025 | 02/12/2025 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 3,074 @ $25.00 | $76.85 K | 127,634 | 02/11/2025 | 02/12/2025 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 11,375 @ $24.04 | $273.46 K | 419,173 | 02/11/2025 | 02/12/2025 | |
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 15,000 @ $25.00 | $375.00 K | 63,654 | 02/11/2025 | 02/12/2025 | |
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 9,244 @ $25.00 | $231.10 K | 54,410 | 02/11/2025 | 02/12/2025 | |
|
Baynes Roy D.
Director |
Sell | 10,000 @ $22.00 | $220.00 K | 31,000 | 02/06/2025 | 02/10/2025 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 1,066 @ $20.11 | $21.44 K | 84,170 | 02/04/2025 | 02/04/2025 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 5,166 @ $20.12 | $103.94 K | 122,708 | 02/03/2025 | 02/04/2025 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 5,192 @ $20.12 | $104.46 K | 90,038 | 02/03/2025 | 02/04/2025 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 8,951 @ $19.78 | $177.05 K | 89,482 | 02/03/2025 | 02/04/2025 | |
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 3,348 @ $20.12 | $67.36 K | 63,654 | 02/03/2025 | 02/04/2025 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 50,691 @ $20.21 | $1.02 M | 430,548 | 02/03/2025 | 02/04/2025 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 4,207 @ $20.12 | $84.65 K | 85,236 | 02/03/2025 | 02/04/2025 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 8,951 @ $19.78 | $177.05 K | 95,719 | 02/03/2025 | 02/04/2025 | |
|
Baynes Roy D.
Director |
Sell | 16,000 @ $20.00 | $320.00 K | 31,000 | 01/23/2025 | 01/23/2025 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 865 @ $18.94 | $16.38 K | 73,730 | 01/22/2025 | 01/23/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Travere Therapeutics, Inc. FAQ's
The list of insiders at Travere Therapeutics, Inc. includes Calvin Sandra, Inrig Jula, ROTE WILLIAM E., Dube Eric M, REED ELIZABETH E, Heerma Peter, Cline Christopher R., Baynes Roy D..
Insiders have sold a total of 207.14 K Travere Therapeutics, Inc. shares in the last 12 months for a total of 4.36 M sold.
The following insiders have sold Travere Therapeutics, Inc. shares in the last 12 months: Calvin Sandra ($949.26 K), Inrig Jula ($214.22 K), ROTE WILLIAM E. ($346.83 K), Dube Eric M ($1.51 M), REED ELIZABETH E ($412.71 K), Heerma Peter ($271.22 K), Cline Christopher R. ($121.48 K), Baynes Roy D. ($540.00 K),